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Introduction
IIb/ 3 is a prototypic member of the integrin superfamily of cell surface receptors that include the receptors for such ligands as von Willebrand factor, fibrinogen, vitronectin, fibronectin and collagen 1 . IIb/ 3 is found at high levels only on the surface of megakaryocytes and platelets 2 .
The ~80,000 copies of IIb/ 3 found on the platelet surface make it the most abundant receptor present, representing half of the total molar number of receptors 3 . Normal function of this receptor is critical for platelet function during thrombus development 4 .
The tissue-specificity of the IIb/ 3 receptor is determined by IIb. While 3 is expressed as part of the v/ 3 vitronectin receptor on many tissues, IIb expression is limited to hematopoietic tissue, and achieves high-levels of expression only in developing megakaryocytes 5, 6 . In both the human and mouse genomes, there exists a single IIb gene, which contains 30 exons and spans a distance of ~18 kb along chromosomes 17 and 11, respectively 7, 8 . In vitro studies in megakaryocytic-like cell lines have defined important tissue-specific regulatory domains in the immediate 5'-flanking region, including proximal (-55 bp upstream from the transcriptional start site) and distal (-480 bp) GATA-1 DNA binding sites, each associated with an adjacent Ets binding site 9, 10 , as well as a potential silencer region located between the two GATA/Ets motifs 11 .
These in vitro studies, which determined that ~600 bp of 5' flanking of the IIb gene proximal promoter region is sufficient to support tissue-specific expression, have been consistent with in vivo transgenic murine studies. In those reports, as little as 787 bp of the 5'-flanking region of the IIb gene was used to drive thymidine kinase (TK) toxigene expression in the megakaryocytes of transgenic mice 12 . Using gancyclovir as the toxic agent, these studies demonstrated TK expression predominantly in the bone marrow. In these studies, the relative level of expression of the reporter gene was not determined, as even low levels of thymidine kinase expression would make cells susceptible to gancyclovir. Hence, these in vivo studies, although indicating domains important for
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In this regard, we wished to pursue the molecular basis of IIb gene expression in vivo, by focusing not only on the proximal promoter region, but also examining more distal intergenic regions in the IIb gene locus. The difficulty in examining these intergenic regions lies in their broad size. One technique for localizing regulatory domains within a large expanse of DNA sequence is phylogenetic footprinting. In this approach, nucleotide sequences of two or more species are compared. Functionally important intergenic regulatory regions are less likely to diverge than the remaining intergenic sequence and hence are highlighted by their own conservation 13, 14 . A second approach for defining functional cis-regulatory elements takes advantage of the fact that regulatory regions are often embedded in less compacted chromatin as reflected in their greater susceptibility to digestion by general endonucleases such as Deoxyribonuclease (DNase) I 15, 16 . For example, in the upstream region of the -globin gene locus, there are multiple DNase I hypersensitive (HS) sites that comprise a region essential for high-level expression of the various -globin genes [17] [18] [19] . A third approach involves transgenic animals containing various lengths of a gene and its flanking regions.
Such studies can define important distal elements that regulate tissue-specificity, copy-number dependency and levels of expression relative to the native gene 18, [20] [21] [22] . These intergenic regions are often not only functionally important, but also conserved between species. For example, transgenic studies of the Platelet Basic Protein (PBP) /Platelet Factor 4 (PF4) double gene locus, identified a region between 2.5 and 4.5 kb upstream of the human PBP gene that appears to be an important enhancer of PBP expression and that is also highly conserved between the human and mouse PBP/PF4 gene loci 22 .
In the studies described below, we employ phylogenetic footprinting to compare the human and mouse flanking sequences and define a series of intergenic conserved regions. Several of these 
Experimental Procedures
Phylogenetic footprinting and sequence analysisSequence determination and analysis of the human and murine IIb gene locus was performed as previously described 8, 23 . Generated sequences were submitted to the Genbank public database at Preparation of cell nuclei for DNase I treatment was as previously described 29 . Nuclei from 1 X 10 8 cells were centrifuged for 10 minutes at 500g, and were suspended in 4.5 ml of DNase I buffer (10 mM Tris, pH 7.5, 10 mM NaCl, 5 mM MgCl 2 , 0.1 mM phenylmethylsulfonyl fluoride, 5 mM Na Butyrate, and 1 mM CaCl 2 ). Aliquots of 500 µl of nuclei were added to 500 µl of DNase I buffer containing DNase I enzyme (GIBCO/BRL) varying from 0 to 3.4 µg/ml. The tubes were gently mixed, then placed at 37°C for 5 min and then replaced back on ice. Genomic DNA was recovered and digested further with either Eco RI or Bam HI restriction enzymes for Southern blot analysis as previously described 29, 30 . The probes used for detection were produced via PCR amplification.
Primers used to generate these probes were the following sense/antisense pairs: IIb exon 1 (P1) 7 : 23 .
Transgenic constructs-
The Sal I fragment used to make the 2. Positive founder lines with intact h IIb genes by Southern and PCR analysis were further characterized for copy number by Southern blot. Tail genomic DNA was digested with Eco RI and size separated on a 0.8% (w/v) agarose gel. The Southern blot and copy-number determination procedures were as described before 22, 23 .
Tissue and platelet reverse transcriptase (RT)-PCR analysis-
RNA isolation and RT-PCR procedures for all mRNA expression analysis, as well as a list of the eleven tissues examined have been described before in our previous transgenic studies 22 . Briefly, 
Control experiments, included studies where no reverse transcriptase was added and others treated with RNase A (Sigma) prior to the RT step, were done to ensure that PCR bands seen in the experiments were not generated via pre-RT sources of DNA 22 . Also, control experiments to control for genomic DNA contamination were done where the RNA was treated with DNase I (Invitrogen),
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To quantitate the level of h IIb transgene mRNA expression in platelets relative to endogenous m IIb, we employed methods previously described 18, 20, 22 . Briefly, PCR reactions from first-strand cDNA of platelet RNA were set up using the primers described above and the cycle number at The signals were further normalized for differences in the ability of the primer/PCR conditions to amplify h IIb and m IIb from equal molar amounts of the appropriate cDNA control template as described before 22 . These normalized values were used to compare transgene expression level amongst the different founder lines.
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Protein detection-
Platelet -rich plasma (PRP) from human and mice blood was isolated as described 22 . For these studies, prostaglandin E 1 (Sigma) was added to a final concentration of 1 µM prior to spinning down the platelets at 800 g for 10 mins at RT. The pellets were washed twice in platelet buffer (PB;
134 mM NaCl, 3 mM KCl, 0. 
Results

Phylogenic footprinting of the IIb gene locus-
To search for upstream and downstream distal, intergenic regulatory elements in the IIb gene locus, we employed a cross-species sequence comparison to define evolutionarily-constrained regions that may reflect important functional domains. We previously reported on the sequencing of ~30 kb region surrounding the human and murine IIb gene loci 7, 8, 23 [GenBank Accession numbers: AF170316; AF169829; AF160252; and M33320]). In the present study, we have extended our sequencing of the murine locus (accession number: AF489555) and used our collective sequences together with partially complete public and private database sequences 
DNase I HS mapping of the 5'-and 3'-intergenic regions of IIb-
As an additional method for defining distal cis regions that could potentially be involved in controlling the platelet-specific expression of the IIb gene, we also carried out DNase I sensitivity mapping on chromatin from active (megakaryocytic) h IIb-expressing tissue, versus those from inactive (non-megakaryocytic) non-expressing tissue. Nuclei were isolated and subjected to limited DNase I digestion followed by Eco RI restriction and analysis by Southern blot. A series of bands were seen on genomic Southern blots with a probe P1, covering IIb exon 1 (Figure 2A and 2C) . The second band, which is slightly longer and more intense (~3.7 kb), appears at the same point as the 3.1 kb band and eventually digested away at the higher DNase I concentrations. Consistent results were observed using an additional restriction enzyme, Bam HI, with HEL, CHRF (megakaryocytic) and HeLa cell lines and using a probe P2, covering exon 4 (data not shown, but see Figure 2C ). The Bam HI studies also showed an additional tissue-specific HS site in the immediate promoter region (HS "P" in Figure 2C ). It is of interest that the tissue-specific HS Figure 2B and 2C). As these HS regions were absent in the SNU-1 cells, these HS domains appear to be tissue-specific. Although HS region V is very faintly represented we believe it is a HS domain.
Firstly, it appears in both lanes 3 and 4 (from left side of the blot). Secondly, in other experiments using a lower concentration range of DNase I it also appeared with even greater presence (data not shown). This suggests that it may be a short-lived series of fragments only present within a narrow time period. It appears that HS domains V-VII do not exist as clear distinct bands, but rather as a broader series of DNase I/Eco RI bordered fragments within each HS domain. In contrast to restriction sites which have a single cleavage point within a 4-8 nucleotide recognition sequence, HS can vary in size from 200 bp to >800 bp 37 , and are non-specifically cleaved. Hence it is likely that HS V-VII in Figure 2B represent larger extended hypersensitive domains. These domains are not present at the lowest DNase I concentration then faintly appear within the 2 nd lane from the left of the HEL blot reaching maximum intensity in the 3 rd lane. Note also that none of the broad bands are present at the highest DNase I level. These types of broad, tissue-specific HS domain has been reported to be present in enhancer-containing regions of other genes such as the Myo D musclespecific enhancer 38 , which is localized ~20 kb upstream of the gene. In this enhancer the broad HS this, it appears that some of the tissue-specific HS domains of our IIb 3' locus overlap with conserved intergenic domains in Figure 1 . In particular, the HS region VII overlaps with the conserved domain at +22 kb (Figure 1, vertical arrow "2") .
IIb transgenic mice-
The identification of at least 5 tissue-specific DNase I HS domains located in the flanking intergenic regions of IIb, some of which coincide with conserved domains, suggests the presence of corresponding control elements that might be essential for establishing appropriate transcriptional activation and critical for generating high levels of h IIb on the surface of murine platelets. To test this, a series of transgenic mice containing one of three different h IIb constructs were made To determine the relative level of platelet h IIb transgene expression to the levels of endogenous m IIb, semi-quantitative RT-PCR was performed using platelet total RNA 18, 20, 22 . Species-specific primer pairs were used to detect both species' IIb transcripts. Samples from six consecutive PCR cycles taken during the exponential range of amplification were obtained for both mouse and human primer sets. In total, the levels of 180 RT-PCR amplification products were measured for each experiment (3 experiments collectively) using fluorescent-modified antisense primers.
Additionally, values obtained were corrected for differences in primer efficiency for the detection of their respective transcripts. The summary of these studies are shown in Figure 4B which indicates the platelet h IIb mRNA relative expression versus native m IIb gene expression, for each founder line plotted against its corresponding copy number.
The range of expression for the 2.5 h IIb constructs was from 7.5 x 10 3 fold to 1.5 x 10 2 less than that of the endogenous mRNA level. These values were also not copy-number dependent. Indeed, the lowest copy line had the highest expression. For the 7.1h IIb line, the range of expression was 
with those studies, and demonstrate that a minimal 5'-promoter can restrict IIb expression to megakaryocytes and platelets. But in addition, we now add to those previous studies, by analyzing transgene expression relative to native IIb mRNA levels. Our data reveal that 2.5 kb of 5' flanking region, while tissue-specific is insufficient to direct high levels of IIb in vivo. We estimate that the transgenic mice in the earlier toxigene reporter system studies using either 780 bp of the h IIb promoter or ~ 2.7 kb of the 5'-region of the m IIb promoter to drive expression 12, 39 , most likely expressed their transgenes at a ~0.1-1% of the native m IIb gene expression. Perhaps that is why a toxigene reporter model was successful for monitoring expression, as even low expression levels could be phenotypically detected. We would also predict that in those models that expression levels would not have been copy-number dependent (see below). found tissue-specific HS sites that overlap with a conserved domain and this domain is a strong candidate for containing an enhancer, as other enhancer elements for other genes have been shown to share these structural features 42, 43 . The alignment of this conserved domain for the human and Figure 7 , and was analyzed for consensus-binding sites of transcription factors known to be involved in megakaryopoiesis. Unlike the -globin upstream HS sites, which contain a number of NF-E2 binding sites 44, 45 , there are no NF-E2 binding sites in the analyzed IIb regions. Mice lacking NF-E2 have considerable megakaryocytic defects, however these studies did not examine IIb expression levels 45 . The only previously defined megakaryocyte-specific enhancer is upstream of the PBP gene 22 and it too has no NF-E2 sites. In addition, neither regions have conserved-binding sites for the AML-1 transcription factor, which is also involved in other megakaryocyte-specific genes may provide important insights into the mechanism(s) by which these tissue-specific genes are highly expressed during megakaryopoiesis. Predicted exons for the newly defined hCP44813 gene are shown above the gray shaded homology matches, formerly thought to be areas of non-coding sequence. Gray-filled exons within hCP44813 denote predicted alternatively spliced exon locations. Abbreviations: GRN= Granulin; RPIP8= Rap interacting protein 8; CGI-69= Cell Growth Inhibitor-69; EPB3= Erythrocyte protein band 3.
While the 2.5 h IIb
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